315963242logo-pharma-essentia-v2-01-1

New ropeginterferon alfa-2b Data Suggest Alternate Dosing Schedule May Achieve Greater and Quicker Complete Hematologic and Molecular Responses in Polycythemia Vera

TAIPEI--(BUSINESS WIRE)--PharmaEssentia Corporation (TPEx:6446), a leading fully integrated biopharmaceutical company in Taiwan, today announced the publication of new results from...

HIBIKI_PATH_ADVISORS_4371397_white_RGB

Based on the Results of 52nd Annual General Meeting of Japan Pure Chemical Corporation, Hibiki Path Advisors Will Continue to Actively Engage With the Management in Order to Improve Value for All Shareholders

TOKYO--(BUSINESS WIRE)--Hibiki Path Advisors (“Hibiki” and “We”) is a Singapore-based value and engagement investment firm. Considering the results of the...